000 01475 a2200445 4500
005 20250517205613.0
264 0 _c20180724
008 201807s 0 0 eng d
022 _a1471-2377
024 7 _a10.1186/s12883-018-1038-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLorente, Leonardo
245 0 0 _aHigh serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.
_h[electronic resource]
260 _bBMC neurology
_cMar 2018
300 _a32 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Observational Study
650 0 4 _aAged
650 0 4 _aArea Under Curve
650 0 4 _aBiomarkers
_xblood
650 0 4 _aFemale
650 0 4 _aGlasgow Coma Scale
650 0 4 _aHumans
650 0 4 _aInfarction, Middle Cerebral Artery
_xblood
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aKeratin-18
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
700 1 _aMartín, María M
700 1 _aPérez-Cejas, Antonia
700 1 _aRamos, Luis
700 1 _aArgueso, Mónica
700 1 _aSolé-Violán, Jordi
700 1 _aCáceres, Juan J
700 1 _aJiménez, Alejandro
700 1 _aGarcía-Marín, Victor
773 0 _tBMC neurology
_gvol. 18
_gno. 1
_gp. 32
856 4 0 _uhttps://doi.org/10.1186/s12883-018-1038-z
_zAvailable from publisher's website
999 _c28212751
_d28212751